Abstract
The isolation of a new type of thrombin inhibitor, called triabin, from the saliva of the hematophagous bug Triatoma pallidipennis, has recently been described. In the in vitro platelet aggregation inhibition assay triabin has a similar potency as the thrombin inhibitor hirudin now in phase III clinical trials. However, in another in vitro assay using a low molecular weight substrate for thrombin, triabin does not inhibit thrombin completely even at 6 fold higher molar doses in comparison with hirudin. This means that triabin has a novel mode of action towards thrombin making triabin into an interesting candidate as a therapeutic agent. Recently it has been shown that a recombinant baculovirus can be efficiently used for the triabin production in insect cells and that the yields in adherent cultures of High Five™ cells (approx. 20 mg l-1) were about 7 fold higher than in adherent cultures of Sf9 cells (approx. 3 mg l- 1). To optimize the triabin yield from the baculovirus/insect cell expression system, experiments were performed with suspension adapted cultures of High Five™ cells to investigate the effects of the state of the host cell, of the multiplicity of infection, of the cell density at the time of infection and of supplementation of the medium with nutrients and oxygen. Triabin yields of up to 200 mg l-1, as determined by an activity assay, could finally be obtained here.
Keywords: baculovirus expression system, High Five™, cells, thrombin inhibition, triabin
Full Text
The Full Text of this article is available as a PDF (116.6 KB).
References
- Bober H. Über Möglichkeiten der HPLC zur Trennung und Bestimmung von Aminosäuren. München: Beckman Instruments; 1986. [Google Scholar]
- Chico E, Kobold A, Haase B, Jaeger V. Characterization of growth and recombinant protein production of the insect cell line BTI-Tn-5B1-4 (High Five™) in suspension culture. In: Carrondo MJT, Griffiths B, Moreira JCP, editors. Animal Cell Technology — from Vaccines to Genetic Medicine. Dordrecht: Kluwer Academic Publishers; 1997. pp. 755–760. [Google Scholar]
- Church FC, Phillips J, Woods JL. Chimeric antithrombin peptide, characterization of an arg-gly-asp (RGD)-and hirudin carboxy terminus-containing synthetic peptide. J. Biol. Chem. 1991;288(18):11975–11979. [PubMed] [Google Scholar]
- Davis TR, Wickham TJ, McKenna KA, Granados RR, Shuler ML, Wood HA. Comparative recombinant protein production of eight insect cell lines. In Vitro Cell. Dev. Biol. 1993;29A:388–390. doi: 10.1007/BF02633986. [DOI] [PubMed] [Google Scholar]
- Fuentes-Prior P, Noeske-Jungblut C, Donner P, Schleuning WD, Huber R, Bode W. Structure of the thrombin complex with triabin, a lipocalin-like exosite-binding inhibitor derived from a triatomine bug. Proc. Natl. Acad. Sci. USA. 1997;94:11845–11850. doi: 10.1073/pnas.94.22.11845. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kioukia N, Nienow AW, Emery AN, Al-Rubeai M. Physiological and environmental factors affecting the growth of insect cells and infection with baculovirus. J. Biotechnol. 1995;38:243–251. doi: 10.1016/0168-1656(94)00128-Y. [DOI] [PubMed] [Google Scholar]
- Noeske-Jungblut C, Haendler B, Donner P, Alagon A, Possani L, Schleuning WD. Triabin, a highly potent exosite inhibitor of thrombin. J. Biol. Chem. 1995;270(48):28629–28634. doi: 10.1074/jbc.270.48.28629. [DOI] [PubMed] [Google Scholar]
- Petri T, Neukamm B, Isernhagen M, Ockert B, Noeske-Jungblut C. Expression of triabin, a novel highly potent inhibitor of thrombin, in Sf9 and High Five™ insect cells using a recombinant baculovirus. In: Carrondo MJT, Griffiths B, Moreira JCP, editors. Animal Cell Technology — from Vaccines to Genetic Medicine. Dordrecht: Kluwer Academic Publishers; 1997. pp. 525–528. [Google Scholar]
- Reid S, Greenfield PF, Power J, Radford KM, Nielsen LK, Wong TKK and Peter C (1995) The use of very low multiplicities of infection with the baculovirus expression vector system. In: Beuvery EC, Griffiths JB and Zeijlemaker WP (eds) Animal Cell Technology — Developments towards the 21st Century (pp. 73-77) Kluwer Academic Publishers, 1995.
- Scott RI, Blanchard JH, Ferguson CHR. Effects of oxygen on recombinant protein production by suspension cultures of Spodoptera frugiperda (Sf-9) insect cells. Enzyme Microbial Technol. 1992;14:798–804. doi: 10.1016/0141-0229(92)90095-6. [DOI] [PubMed] [Google Scholar]
- Vonach B, Hess B, Streiff M, Leist C. Expression of a protein A-fucosyltransferase III fusion protein in insect cells. In: Carrondo MJT, Griffiths B, Moreira JCP, editors. Animal Cell Technology — from Vaccines to Genetic Medicine. Dordrecht: Kluwer Academic Publishers; 1997. pp. 703–707. [Google Scholar]
- Whiting JP, Wafford KA, Pribilla I, Petri T. Channel cloning, mutagenesis and expression — baculovirus expression. In: Ashley RH, editor. Ion Channels, a Practical Approach. Oxford: Oxford University Press; 1995. pp. 133–169. [Google Scholar]
- Wickham TJ, Davis T, Granados RR, Shuler ML, Wood HA. Screening of insect cell lines for the production of recombinant proteins and infectious virus in the baculovirus expression system. Biotechnol. Prog. 1992;8:391–396. doi: 10.1021/bp00017a003. [DOI] [PubMed] [Google Scholar]
- Wickham TJ, Nemerow GR. Optimization of growth methods and recombinant protein production in BTI-Tn-5B1-4 insect cells using the baculovirus expression system. Biotechnol. Prog. 1993;9:25–30. doi: 10.1021/bp00019a004. [DOI] [PubMed] [Google Scholar]
- Woehe G. Einführung in die allgemeine Betriebswirtschaftslehre. 17th edition. München: Verlag Franz Vahlen GmbH; 1990. [Google Scholar]